• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用阿魏酸处理乳腺癌细胞系MDA-MB-231的细胞周期数据。

Data on cell cycle in breast cancer cell line, MDA-MB-231 with ferulic acid treatment.

作者信息

Park Eunmi

机构信息

Department of Food and Nutrition, School of Life Science and Nano-Technology, Hannam University, Daejeon, Republic of Korea.

出版信息

Data Brief. 2016 Feb 12;7:107-10. doi: 10.1016/j.dib.2016.02.001. eCollection 2016 Jun.

DOI:10.1016/j.dib.2016.02.001
PMID:26958638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4764770/
Abstract

Inhibition to repair DNA metabolism to respond to damaged DNA can lead to genetic instability, resulting in cancer cell death (Audeh et al., 2010; Bryant et al., 2005; Farmer et al., 2005; Lukas et al., 2003; Tutt et al., 2010) [1], [2], [6], [8], [11]. Despite of various studies demonstrating efficiency of combination therapy through down-regulation of DNA repair pathway, the suppression effects of DNA repair pathway by chemotherapeutic agents from natural bioactive compounds are less understood (Eitsuka et al., 2014; Kastan et al., 2004; Kawabata et al., 2000; Mancuso et al., 2014) [5], [7], [9]. Here, the data shows that ferulic acid reduced the S-phases post to UV treatment in breast cancer cells and was hypersensitive in breast cancer cells, MDA-MB-231.

摘要

抑制修复DNA代谢以应对受损DNA会导致基因不稳定,从而导致癌细胞死亡(奥德赫等人,2010年;布赖恩特等人,2005年;法默等人,2005年;卢卡斯等人,2003年;塔特等人,2010年)[1],[2],[6],[8],[11]。尽管各种研究表明通过下调DNA修复途径进行联合治疗的有效性,但天然生物活性化合物中的化疗药物对DNA修复途径的抑制作用却鲜为人知(江冢等人,2014年;卡斯唐等人,2004年;川端等人,2000年;曼库索等人,2014年)[5],[7],[9]。在此,数据表明阿魏酸减少了乳腺癌细胞紫外线处理后的S期,并且在乳腺癌细胞MDA-MB-231中具有高敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/4764770/953576639479/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/4764770/07601b08568d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/4764770/953576639479/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/4764770/07601b08568d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2598/4764770/953576639479/gr2.jpg

相似文献

1
Data on cell cycle in breast cancer cell line, MDA-MB-231 with ferulic acid treatment.用阿魏酸处理乳腺癌细胞系MDA-MB-231的细胞周期数据。
Data Brief. 2016 Feb 12;7:107-10. doi: 10.1016/j.dib.2016.02.001. eCollection 2016 Jun.
2
Data on the effects of anti-cancer drug of resveratrol in breast cancer cells, MDA-MB-231 cells.白藜芦醇抗癌药物对乳腺癌细胞MDA - MB - 231细胞作用的数据。
Data Brief. 2017 Mar 21;12:68-71. doi: 10.1016/j.dib.2017.03.029. eCollection 2017 Jun.
3
DIBI, a novel 3-hydroxypyridin-4-one chelator iron-binding polymer, inhibits breast cancer cell growth and functions as a chemosensitizer by promoting S-phase DNA damage.DIBI,一种新型 3-羟基吡啶-4-酮螯合铁结合聚合物,通过促进 S 期 DNA 损伤来抑制乳腺癌细胞生长并作为化疗增敏剂发挥作用。
Biometals. 2019 Dec;32(6):909-921. doi: 10.1007/s10534-019-00222-3. Epub 2019 Oct 17.
4
Ferulic acid in combination with PARP inhibitor sensitizes breast cancer cells as chemotherapeutic strategy.阿魏酸与聚(ADP - 核糖)聚合酶抑制剂联合使用可使乳腺癌细胞致敏,作为一种化疗策略。
Biochem Biophys Res Commun. 2015 Mar 13;458(3):520-524. doi: 10.1016/j.bbrc.2015.01.147. Epub 2015 Feb 10.
5
Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.转化生长因子β1和β2是人类乳腺癌细胞系的等效生长抑制剂。
J Cell Physiol. 1989 Nov;141(2):353-61. doi: 10.1002/jcp.1041410217.
6
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.与肿瘤相关脂肪酸合酶依赖性乳腺癌细胞增殖和存活相关的新型信号分子:外源性膳食脂肪酸、p53-p21WAF1/CIP1、ERK1/2 MAPK、p27KIP1、BRCA1和NF-κB的作用
Int J Oncol. 2004 Mar;24(3):591-608.
7
Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.苯乙烯取代双香豆素的细胞效应导致人乳腺癌细胞发生细胞凋亡和细胞周期阻滞。
Int J Biochem Cell Biol. 2017 Nov;92:104-114. doi: 10.1016/j.biocel.2017.09.019. Epub 2017 Sep 25.
8
Genetic risk profiles for cancer susceptibility and therapy response.癌症易感性和治疗反应的遗传风险概况。
Recent Results Cancer Res. 2007;174:19-36. doi: 10.1007/978-3-540-37696-5_2.
9
Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.前胰岛素样生长因子-I的E肽对发育中鸡胚尿囊绒毛膜上侵袭性人乳腺癌细胞(MDA-MB-231)生长及癌诱导血管生成的抑制作用
J Cell Biochem. 2007 Aug 1;101(5):1316-27. doi: 10.1002/jcb.21254.
10
Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.酰基辅酶 A 合成酶 4 参与涉及能量依赖型转运体表达调控的乳腺癌细胞系耐药。
Biochem Pharmacol. 2019 Jan;159:52-63. doi: 10.1016/j.bcp.2018.11.005. Epub 2018 Nov 9.

引用本文的文献

1
Ferulic Acid: A Natural Phenol That Inhibits Neoplastic Events through Modulation of Oncogenic Signaling.阿魏酸:一种天然酚类化合物,通过调节致癌信号抑制肿瘤发生。
Molecules. 2022 Nov 7;27(21):7653. doi: 10.3390/molecules27217653.
2
Computer-aided drug design and inhibitive effect of a novel nitrogenous heterocyclic compound and its mechanism on glioma U251 cells and breast cancer MCF-7 cells.新型含氮杂环化合物的计算机辅助药物设计、抑制作用及其对胶质瘤U251细胞和乳腺癌MCF-7细胞的作用机制
Drug Des Devel Ther. 2018 Jun 27;12:1931-1939. doi: 10.2147/DDDT.S168130. eCollection 2018.
3
Statistical data analysis of cancer incidences in insurgency affected states in Nigeria.

本文引用的文献

1
Curcumin enhances poly(ADP-ribose) polymerase inhibitor sensitivity to chemotherapy in breast cancer cells.姜黄素增强乳腺癌细胞对聚(ADP - 核糖)聚合酶抑制剂化疗的敏感性。
J Nutr Biochem. 2015 Dec;26(12):1442-7. doi: 10.1016/j.jnutbio.2015.07.015. Epub 2015 Aug 8.
2
Ferulic acid in combination with PARP inhibitor sensitizes breast cancer cells as chemotherapeutic strategy.阿魏酸与聚(ADP - 核糖)聚合酶抑制剂联合使用可使乳腺癌细胞致敏,作为一种化疗策略。
Biochem Biophys Res Commun. 2015 Mar 13;458(3):520-524. doi: 10.1016/j.bbrc.2015.01.147. Epub 2015 Feb 10.
3
Synergistic inhibition of cancer cell proliferation with a combination of δ-tocotrienol and ferulic acid.
尼日利亚受叛乱影响各州癌症发病率的统计数据分析。
Data Brief. 2018 May 5;18:2029-2046. doi: 10.1016/j.dib.2018.04.135. eCollection 2018 Jun.
4
Breast cancer patients in Nigeria: Data exploration approach.尼日利亚的乳腺癌患者:数据探索方法。
Data Brief. 2017 Sep 1;15:47-57. doi: 10.1016/j.dib.2017.08.038. eCollection 2017 Dec.
5
Combined Analysis of ChIP Sequencing and Gene Expression Dataset in Breast Cancer.乳腺癌中染色质免疫沉淀测序与基因表达数据集的联合分析
Pathol Oncol Res. 2017 Apr;23(2):361-368. doi: 10.1007/s12253-016-0116-z. Epub 2016 Sep 21.
δ-生育三烯酚与阿魏酸联合使用对癌细胞增殖的协同抑制作用。
Biochem Biophys Res Commun. 2014 Oct 24;453(3):606-11. doi: 10.1016/j.bbrc.2014.09.126. Epub 2014 Oct 5.
4
Ferulic acid: pharmacological and toxicological aspects.阿魏酸:药理学和毒理学方面。
Food Chem Toxicol. 2014 Mar;65:185-95. doi: 10.1016/j.fct.2013.12.024. Epub 2013 Dec 25.
5
Inactivation of Uaf1 causes defective homologous recombination and early embryonic lethality in mice.Uaf1 的失活导致小鼠同源重组缺陷和胚胎早期致死。
Mol Cell Biol. 2013 Nov;33(22):4360-70. doi: 10.1128/MCB.00870-13. Epub 2013 Sep 3.
6
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.奥拉帕利在携带 BRCA1 或 BRCA2 突变的复发性卵巢癌患者中的疗效:一项概念验证试验。
Lancet. 2010 Jul 24;376(9737):245-51. doi: 10.1016/S0140-6736(10)60893-8. Epub 2010 Jul 6.
7
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.奥拉帕利治疗携带 BRCA1 或 BRCA2 突变的晚期乳腺癌患者的疗效:一项概念验证试验。
Lancet. 2010 Jul 24;376(9737):235-44. doi: 10.1016/S0140-6736(10)60892-6. Epub 2010 Jul 6.
8
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.将BRCA突变细胞中的DNA修复缺陷作为一种治疗策略。
Nature. 2005 Apr 14;434(7035):917-21. doi: 10.1038/nature03445.
9
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.用聚(ADP - 核糖)聚合酶抑制剂特异性杀伤BRCA2缺陷型肿瘤
Nature. 2005 Apr 14;434(7035):913-7. doi: 10.1038/nature03443.
10
Cell-cycle checkpoints and cancer.细胞周期检查点与癌症。
Nature. 2004 Nov 18;432(7015):316-23. doi: 10.1038/nature03097.